在老年患有心肌梗塞的老年患者中,具有或没有ST段升高的完整或仅罪祸首的血管再循环
Marta Cocco1, Gianluca Campo1, Vincenzo Guiducci2
1Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Ferrara, Italy.
Journal of the American College of Cardiology
|September 1, 2024
概括
在老年心肌梗塞 (MI) 患者中,包括ST段升高MI (STEMI) 和非ST段升高MI (NSTEMI) 在内的完整重血栓化,与仅罪祸首重血栓化相比,持续减少不良结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 临床试验 临床试验
背景情况:
- 完整的重血管化已被证明对ST段升高心肌梗塞 (STEMI) 有效.
- 它在非ST段升高心肌梗塞 (NSTEMI) 的有效性需要进一步研究.
- 患有多血管疾病的老年患者在重血管化策略中存在独特的挑战.
研究的目的:
- 在患有STEMI和NSTEMI的老年患者中,比较完整的再血管化与罪祸首的再血管化结果.
- 评估完整的再血管化是否在老年人中在不同类型的MI中提供一致的好处.
- 评估生理学引导的完整重血管化的对主要心血管不良事件的影响.
主要方法:
- 在FIRE试验中,有1,445名老年心脏病患者被随机分类,接受仅罪祸首或生理学导向的完全重血管化.
- 患者根据STEMI和NSTEMI呈现分层.
- 主要结局是1年后死亡,心脏病发作,中风或再血管化的综合结局;一个关键的次要结局是1年后心血管死亡或心脏病发作.
主要成果:
- 由生理学指导的完全重血管化显著降低了整体人口中的主要结果.
- 在STEMI患者中,主要结局发生在21.1% (仅罪祸首) 和16.2% (完整) 的患者中.
- 在NSTEMI患者中,主要结局发生在20.9% (仅罪祸首) 和15.4% (完整) 的患者中,MI类型和治疗效果之间没有显著的相互作用.
结论:
- 通过生理学引导的完整重血管化为患有心脏病的老年患者提供了一致的好处,无论STEMI或NSTEMI呈现如何.
- 这一策略与死亡率,心脏病发作,中风或一年后再血管化的降低有关.
- 这些发现支持将完整的重血管化作为老年人心脏病频谱中有益的方法.
更多相关视频
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
18.5K
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.3K
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...